No Record Found
Sector
PharmaceuticalsOpen
₹30.43Prev. Close
₹28.99Turnover(Lac.)
₹0.85Day's High
₹30.43Day's Low
₹27.5652 Week's High
₹36.9652 Week's Low
₹6.27Book Value
₹8.37Face Value
₹10Mkt Cap (₹ Cr.)
15.64P/E
0EPS
0.03Divi. Yield
02 Sep 2025
12:00 AM
BookCloser
5 Nov 2025
12:00 AM
Board Meeting
Agenda : Audited Result
11 Jan 2025
12:00 AM
EGM
2 Sep 2025
12:00 AM
AGM
Announcement Date: 02 Sep, 2025
No Record Found
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 10.31 | 5.24 | 5.24 | 5.24 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | -5.9 | -5.89 | -5.95 | -6.18 |
Net Worth | 4.41 | -0.64 | -0.71 | -0.94 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 0.47 | 0.15 | 0 | 0.25 |
yoy growth (%) | 212.02 | 0 | -100 | -86.57 |
Raw materials | -0.31 | -0.09 | 0 | -0.24 |
As % of sales | 67.2 | 60.93 | 0 | 94.21 |
Employee costs | -0.21 | -0.1 | -0.05 | -0.06 |
| Y/e 31 Mar( In .Cr) | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -0.26 | -0.24 | -0.24 | -0.49 |
Depreciation | -0.01 | 0 | 0 | 0 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.01 | -0.14 | 0.01 | -0.16 |
Other operating items |
| Y/e 31 Mar | Mar-2020 | Mar-2019 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 212.02 | 0 | -100 | -86.57 |
Op profit growth | 6.49 | -1.4 | -60.68 | 346.75 |
EBIT growth | 10.95 | -0.86 | -50.68 | 256.19 |
Net profit growth | 15.28 | -2.01 | -81.87 | 868.92 |
No Record Found
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,716.05 | 88.09 | 4,11,737.88 | 564.22 | 0.93 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,534.1 | 69 | 1,73,459.82 | 696 | 0.46 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,825.6 | 60.67 | 1,29,469.87 | 597 | 0.16 | 2,707 | 249.83 |
Cipla Ltd CIPLA | 1,514.8 | 23.54 | 1,22,361.18 | 1,210.53 | 1.06 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,211.35 | 18.73 | 1,01,100.94 | 387.3 | 0.66 | 4,602.9 | 377.57 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Whole-time Director
Sadhanala Venkata Rao
Non-Exec & Non-Independent Dir
Swapneswar Mishra
Non-Exec & Non-Independent Dir
D. Rakesh Reddy
Independent Non Exe. Director
Mr Reddeppa Gundluru
Independent Non Exe. Director
Dakshita Jain
Company Sec. & Compli. Officer
Priyanka Agarwal
Sy No 115 Brig Sayeed Road,
Hanumanji Colony Old Bowenpall,
Telangana - 500009
Tel: -
Website: http://www.venmaxdrugs.com
Email: venmaxdrugs@gmail.com
214 RaghavaRatna Tow,
Chiragali Lane, Abids,
Hyderabad 500001
Tel: 91-040-23202465/2320
Website: www.cilsecurities.com
Email: cilsec@hotmail.com
Summary
Venmax Drugs & Pharmaceuticals Limited, (VDPL) was initially incorporated as Private Company as Yenkay Medico Private Limited, on 28 September, 1998. The Company thereafter changed its name to Yenkey ...
Read More
Reports by Venmax Drugs & Pharmaceuticals Ltd
What is the Venmax Drugs & Pharmaceuticals Ltd share price today?
What is the Market Cap of Venmax Drugs & Pharmaceuticals Ltd?
What is the PE and PB ratio of Venmax Drugs & Pharmaceuticals Ltd?
What is the 52 Week High and Low of Venmax Drugs & Pharmaceuticals Ltd?
What is the CAGR of Venmax Drugs & Pharmaceuticals Ltd?
What is the shareholding pattern of Venmax Drugs & Pharmaceuticals Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.